{"id":312311,"date":"2020-01-08T17:56:28","date_gmt":"2020-01-09T01:56:28","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/healthcare-roundup-fda-oks-merck-keytruda-catabasis-pharma-teams-up-with-uk-dmd-charity\/"},"modified":"2020-01-08T17:56:45","modified_gmt":"2020-01-09T01:56:45","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-fda-%e6%89%b9%e5%87%86%e9%bb%98%e5%85%8b%e5%85%ac%e5%8f%b8%e7%9a%84-keytruda-%e6%b2%bb%e7%96%97%e6%8a%97%e8%8d%af%e6%80%a7%e8%86%80%e8%83%b1","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/01\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-fda-%e6%89%b9%e5%87%86%e9%bb%98%e5%85%8b%e5%85%ac%e5%8f%b8%e7%9a%84-keytruda-%e6%b2%bb%e7%96%97%e6%8a%97%e8%8d%af%e6%80%a7%e8%86%80%e8%83%b1\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014FDA\u6279\u51c6\u9ed8\u514b\u516c\u53f8\u7684Keytruda\u6cbb\u7597\u6297\u836f\u6027\u8180\u80f1\u764c\uff0cCatabasis Pharma\u4e0e\u82f1\u56fdDMD\u6148\u5584\u673a\u6784\u5408\u4f5c\u5f00\u5c55edasalonexent\u7814\u7a76"},"content":{"rendered":"<h3><strong>FDA<\/strong><strong>\u6279\u51c6\u9ed8\u514b\u516c\u53f8\u7684<\/strong><strong>Keytruda<\/strong><strong>\u6cbb\u7597\u6297\u836f\u6027\u8180\u80f1\u764c<\/strong><\/h3>\n<ul>\n<li>FDA\u6279\u51c6<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=MRK\">\u9ed8\u514b\uff08NYSE\uff1aMRK\uff09<\/a>Keytruda\uff08pembrolizumab\uff09\u4f5c\u4e3a\u5355\u836f\u6cbb\u7597\u5361\u4ecb\u82d7\u82bd\u5b62\u6746\u83cc\uff08BCG\uff09\u65e0\u53cd\u5e94\u3001\u9ad8\u98ce\u9669\u3001\u65e0\u808c\u6d78\u6da6\u6027\u8180\u80f1\u764c\u3001\u539f\u4f4d\u764c\u4f34\u6216\u4e0d\u4f34\u4e73\u5934\u72b6\u7624\u3001\u4e0d\u7b26\u5408\u6216\u5df2\u9009\u62e9\u4e0d\u8fdb\u884c\u8180\u80f1\u5207\u9664\u672f\uff08\u5207\u9664\u8180\u80f1\uff09\u7684\u60a3\u8005\u3002<\/li>\n<\/ul>\n<h2><strong>Catabasis Pharma<\/strong><strong>\u4e0e\u82f1\u56fd<\/strong><strong>DMD<\/strong><strong>\u6148\u5584\u673a\u6784\u5408\u4f5c\u5f00\u5c55<\/strong><strong>edasalonexent<\/strong><strong>\u7814\u7a76<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CATB\">Catabasis\u5236\u836f\u516c\u53f8\uff08CATB-1.6%\uff09<\/a>\u5c06\u4e0e\u4f26\u6566\u675c\u5c1a\u5927\u5b66\u7814\u7a76\u6148\u5584\u673a\u6784Duchenne UK\u5408\u4f5c\uff0c\u8be5\u57fa\u91d1\u4f1a\u4e3a\u675c\u5174\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\uff08DMD\uff09\u7597\u6cd5\u7684\u5f00\u53d1\u63d0\u4f9b\u8d44\u91d1\uff0c\u8be5\u7814\u7a76\u57282\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8bc4\u4f30\u4e86\u4f9d\u8fbe\u5355\u6297\uff08CAT-1004\uff09\u5728\u975e\u52a8\u6001DMD\u60a3\u8005\u4e2d\u7684\u7597\u6548\u3002<\/li>\n<li>\u8fd9\u9879\u4e3a\u671f\u4e00\u5e74\u7684\u7814\u7a76\u7684\u76ee\u6807\u7814\u7a76\u5bf9\u8c61\u662f16\u4f4d\u5e74\u9f84\u81f3\u5c1110\u5c81\u7684\u53c2\u4e0e\u8005\uff08\u65e0\u8bba\u7a81\u53d8\u7c7b\u578b\u5982\u4f55\uff09\uff0c\u4ed6\u4eec\u81f3\u5c11\u516d\u4e2a\u6708\u6ca1\u6709\u63a5\u53d7\u7c7b\u56fa\u9187\u6cbb\u7597\u3002<\/li>\n<\/ul>\n<h2><strong>FDA<\/strong><strong>\u63a5\u53d7<\/strong><strong>Nabriva<\/strong><strong>\u91cd\u65b0\u63d0\u4ea4\u7684<\/strong><strong>Contepo<\/strong><strong>\u7533\u8bf7\uff1b\u76d8\u540e\u80a1\u4ef7\u4e0a\u6da8<\/strong><strong>8%<\/strong><\/h2>\n<ul>\n<li>FDA\u63a5\u53d7<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=NBRV\">Nabriva Therapeutics\uff08NASDAQ\uff1aNBRV\uff09<\/a>\u7684\u590d\u5ba1\u7533\u8bf7\uff0c\u5373Contepo\uff08\u78f7\u9709\u7d20\uff09\u7528\u4e8e\u6cbb\u7597\u590d\u6742\u5c3f\u8def\u611f\u67d3\u7684\u4e0a\u5e02\u7533\u8bf7\u3002<\/li>\n<li>Nabriva Therapeutics\u76d8\u540e\u80a1\u4ef7\u4e0a\u6da88%\u3002<\/li>\n<\/ul>\n<h2><strong>\u8fc8\u5170\u56e0<\/strong><strong>NDMA<\/strong><strong>\u6c61\u67d3\u53ec\u56de<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=MYL\">\u8fc8\u5170\u5236\u836f\uff08MYL-1.2%\uff09<\/a>\u5728\u7f8e\u56fd\u5168\u56fd\u8303\u56f4\u5185\u53ec\u56de\u4e86\u4e09\u6279Nizatidine\u80f6\u56ca\uff0c\u5305\u62ec150\u6beb\u514b\u548c300 \u6beb\u514b\u5242\u91cf\uff0c\u8fd9\u5f52\u56e0\u4e8e\u5370\u5ea6Tamilnadu\u5236\u9020\u7684\u4ea7\u54c1\u4e2d\u6709N-\u4e9a\u785d\u57fa\u4e8c\u7532\u80fa\uff08NDMA\uff09\u6c61\u67d3\u3002<\/li>\n<li>\u8be5\u516c\u53f8\u5df2\u5c06\u6b64\u95ee\u9898\u901a\u77e5\u4e86FDA\u3002<\/li>\n<\/ul>\n<h2><strong>Veracyte<\/strong><strong>\u4e0e<\/strong><strong>Acerta Pharma<\/strong><strong>\u5408\u4f5c<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VCYT\">Veracyte\uff08NASDAQ\uff1aVCYT\uff09<\/a>\u5ba3\u5e03\u4e0e\u963f\u65af\u5229\u5eb7\u8840\u6db2\u5b66\u7814\u53d1\u90e8\u95e8Acerta Pharma\uff08NYSE\uff1aAZN\uff09\u5efa\u7acb\u591a\u5e74\u5408\u4f5c\u5173\u7cfb\uff0c\u4ee5\u63d0\u4f9b\u57fa\u56e0\u7ec4\u4fe1\u606f\u6765\u652f\u6301\u80bf\u7624\u6cbb\u7597\u5b66\u7684\u53d1\u5c55\u3002<\/li>\n<li>\u8d22\u52a1\u548c\u5176\u4ed6\u6761\u6b3e\u672a\u62ab\u9732\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The FDA approves Merck&#8217;s (NYSE:MRK) Keytruda (pembrolizumab) . Catabasis Pharmaceuticals (CATB -1.6%) will partner with Duchenne UK<\/p>\n","protected":false},"author":9,"featured_media":312308,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-312311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/312311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=312311"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/312311\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/312308"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=312311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=312311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=312311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}